Methyl 3-(3-((tert-butoxycarbonyl)amino)azetidin-1-yl)-2-methylpropanoate

Catalog No. :
ACVCAU959
CAS No. :
886364-58-5
Molecular Formula :
C13H24N2O4
Molecular Weight :
272.35

IUPAC Name:methyl 3-(3-((tert-butoxycarbonyl)amino)azetidin-1-yl)-2-methylpropanoate

Methyl 3-(3-((tert-butoxycarbonyl)amino)azetidin-1-yl)-2-methylpropanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$403.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(3-((tert-butoxycarbonyl)amino)azetidin-1-yl)-2-methylpropanoate
IUPAC Namemethyl 3-(3-((tert-butoxycarbonyl)amino)azetidin-1-yl)-2-methylpropanoate
MDL No.MFCD07369876
Molecular FormulaC13H24N2O4
Molecular Weight272.35
SMILESO=C(OC)C(C)CN1CC(NC(OC(C)(C)C)=O)C1
InChI KeyHKMPOZNDOMNVBC-UHFFFAOYSA-N
Synonym1-Azetidinepropanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-.alpha.-methyl-, methyl ester;3-(3-BOC-AMINO-AZETIDIN-1-YL)-2-METHYL-PROPIONIC ACID METHYL ESTER;1-Azetidinepropanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-α-methyl-, methyl ester;3-(3-tert-Butoxycarbonylamino-azetidin-1-yl)-2-methyl-propionic acid methyl ester, CAS 886364-58-5
CAS No.886364-58-5

Synthetic Route by SureRoute

1. ACVCAU959 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKCZX165 route compound structure diagram
    ACKCZX16591188-13-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVCAU959 route product structure diagram
    ACVCAU959886364-58-5
Inquiry

2. ACVCAU959 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKCZX165 route compound structure diagram
    ACKCZX16591188-13-5 In Stock
  2. Plus
  3. ACADWM214 route compound structure diagram
    ACADWM21420609-71-6 In Stock
  4. Then
  5. ACVCAU959 route product structure diagram
    ACVCAU959886364-58-5
Inquiry

Comments (0)